US Stock MarketDetailed Quotes

CLDX Celldex Therapeutics

Watchlist
  • 25.270
  • +0.150+0.60%
Close Dec 31 16:00 ET
  • 21.010
  • -4.260-16.86%
Post 20:01 ET
1.68BMarket Cap-9.79P/E (TTM)

Celldex Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Celldex Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 575.000K--
--2024/Q4-- / 1.307M--
--2024/Q33.191M / 1.074M--
--2024/Q22.498M / 854.290K--
--2024/Q1156.000K / 816.670K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 575.000K--
--2024/Q4-- / 1.307M--
--2024/Q33.191M / 1.074M--
--2024/Q22.498M / 854.290K--
--2024/Q1156.000K / 816.670K--

Unlock Free Earnings Estimates

Celldex Therapeutics Earnings Reports

  • Celldex Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 6, 2024 16:07 ET

  • Celldex Therapeutics | 8-K: Celldex Reports Third Quarter 2024 Financial Results and Provides Corporate Update

    Nov 6, 2024 16:02 ET

  • Celldex Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8, 2024 16:57 ET

  • Celldex Therapeutics | 8-K: Celldex Reports Second Quarter 2024 Financial Results and Provides Corporate Update

    Aug 8, 2024 16:49 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
    AIPUY
    +4.51%
    Precision Drilling
    PDS
    +2.81%
    SilverCrest Metals
    SILV
    +2.02%
    Dorian LPG
    LPG
    +1.50%
    Constellation Brands
    STZ
    +0.61%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Strong Buy

    • Buy

      88.89%

    • Hold

      11.11%

    • Sell

      0.00%

    Price Target

    No Data